Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pharmacokinetics, Pharmacodynamics,”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05421429
What this trial is testing

KN057 Multiple Dose Study in Moderately Severe to Severe Hemophilia

Who this might be right for
Hemophilia
Suzhou Alphamab Co., Ltd. 24
Early research (Phase 1)Not Yet RecruitingNCT07001839
What this trial is testing

A Phase Ib Study of QLS4131 in Subjects With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Qilu Pharmaceutical Co., Ltd. 108
Not applicableStudy completedNCT00508677
What this trial is testing

Mazindol in Children With ADHD : Open-label, Efficacy, Safety and Pharmacokinetic Pilot Trial

Who this might be right for
Attention Deficit Hyperactivity Disorder
Assistance Publique - Hôpitaux de Paris 24
Early research (Phase 1)Temporarily pausedNCT06739707
What this trial is testing

Subcutaneously Administered MD-18 for the Treatment of Obesity and Diabetes

Who this might be right for
Healthy Volunteer
Cohen Global, Ltd. 54
Early research (Phase 1)Looking for participantsNCT07133828
What this trial is testing

Learn About the Safety of BIIB142 and How it is Processed in the Body of Healthy Adult Participants Aged 18 to 55 Years Old

Who this might be right for
Healthy Volunteer
Biogen 78
Early research (Phase 1)Study completedNCT00796471
What this trial is testing

A Pharmacokinetics and Pharmacodynamics Study Under Fasting and Fed Conditions With Paliperidone Extended-release and Immediate-release Formulations

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 35
Early research (Phase 1)Ended earlyNCT03381144
What this trial is testing

The Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of Single and Multiple Ascending Doses of GDC-0334 and the Effect of Food on the Pharmacokinetics of GDC-0334 in Healthy Adult Participants

Who this might be right for
Healthy Volunteers
Genentech, Inc. 66
Early research (Phase 1)Ended earlyNCT06406400
What this trial is testing

Drug-Drug Interaction and Safety of AZD4041 Study (Part 1) and Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of AZD4041 Study in Opioid Use Disorder (Part 2).

Who this might be right for
Opioid Use Disorder
AstraZeneca 15
Not applicableStudy completedNCT07681544
What this trial is testing

Empirical Meropenem Dosing in Critically Ill Patients: Early Assessment of Plasma Exposure and Minimum Inhibitory Concentration Targets

Who this might be right for
Empirical Antimicrobial TherapyCritically IllMeropenem+1 more
Hospital Italiano de Buenos Aires 26
Early research (Phase 1)Study completedNCT02828046
What this trial is testing

An Ascending Dose Study to Evaluate M281 Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD)

Who this might be right for
Healthy Volunteers
Momenta Pharmaceuticals, Inc. 50
Early research (Phase 1)Study completedNCT03965013
What this trial is testing

Look at How Safe NNC0268-0965 is in Healthy People and People With Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1Healthy Volunteers
Novo Nordisk A/S 78
Testing effectiveness (Phase 2)Active Not RecruitingNCT06594146
What this trial is testing

Study of CM313 (SC) Injection in Subjects With Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Primary Immune Thrombocytopenia
Keymed Biosciences Co.Ltd 62
Early research (Phase 1)Study completedNCT07324642
What this trial is testing

MAD Study of KINE-101 in Healthy Volunteers

Who this might be right for
Healthy Volunteers
Kine Sciences Co., Ltd. 24
Early research (Phase 1)Study completedNCT01771874
What this trial is testing

Influence of Bupropion on the Effects of MDMA

Who this might be right for
HealthySubstance-related Disorders
University Hospital, Basel, Switzerland 16
Testing effectiveness (Phase 2)Study completedNCT00776074
What this trial is testing

A Pharmacodynamic Study of Leuprorelin Gelatin-Free Formulation in Female Subjects With Uterine Fibroids.

Who this might be right for
Uterine Fibroids
Takeda 80
Early research (Phase 1)Looking for participantsNCT06873659
What this trial is testing

SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors

Who this might be right for
Solid TumorGastric CancerLiver Cancer
Qurgen Inc. 96
Testing effectiveness (Phase 2)Looking for participantsNCT05855083
What this trial is testing

Efficacy and Safety Study of Narsoplimab in Pediatric Patients With High-Risk Hematopoietic Stem Cell Transplant TMA

Who this might be right for
Thrombotic MicroangiopathiesHematopoietic Stem Cell Transplantation
Omeros Corporation 18
Early research (Phase 1)Study completedNCT00625859
What this trial is testing

Assess the Safety of Repeated Doses of GSK189075 and WELLBUTRIN SR in Healthy Male Subjects

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 27
Early research (Phase 1)Study completedNCT00207103
What this trial is testing

MAD in Cancer Patients: Safety of BMS-582664 in Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
TumorsNeoplasm Metastasis
Bristol-Myers Squibb 68
Early research (Phase 1)Study completedNCT01286103
What this trial is testing

A Pharmacokinetic and Pharmacodynamic Study of Once-Daily and Twice-Daily Dosing With Canagliflozin in Healthy Adult Volunteers

Who this might be right for
Healthy
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 34
Next Page